Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations [Phase 3]

View source ↗

Summary

A Phase 3 study is exploring whether a fixed-dose combination inhaler of fluticasone propionate and albuterol sulfate can prevent asthma exacerbations; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate / albuterol sulfate (Fluticasone propionate + albuterol sulfate)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Asthma | Phase 3 | Status: RECRUITING